Alendronate 70 mg once weekly vs. placebo: Tolerability study in patients with osteoporosis.

被引：0
作者：
Greenspan, SL
Field-Munves, EM
Tonino, RP
Mako, B
Smith, ME
Yates, J
Palmisano, J
机构：
[1] Oteoporosis Prevent & Treatment Ctr, Pittsburgh, PA USA
[2] Springhouse Profess Ctr, Allentown, PA USA
[3] Good Hlth, Burlington, VT USA
[4] Merck & Co Inc, W Point, PA USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2001年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S405 / S405
页数：1
相关论文
共 50 条
  • [21] Upper GI tolerability of once-weekly alendronate 70 mg with concomitant NSAID use
    De Papp, AE
    Palmisano, J
    Sackarowitz, JT
    Geba, GP
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09) : S52 - S53
  • [22] Upper gastrointestinal tolerability of once-weekly alendronate 70 mg with concomitant NSAID use
    De Papp, A
    Palmisano, J
    Petruschke, R
    Geba, G
    GASTROENTEROLOGY, 2003, 124 (04) : A168 - A168
  • [23] Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis
    Sebba, AI
    Bonnick, SL
    Kagan, R
    Thompson, DE
    Skalky, CS
    Chen, EL
    de Papp, AE
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (12) : 2031 - 2041
  • [24] Alendronate 70 mg once weekly is therapeutically equivalent to alendronate 10 mg daily
    Tonino, R
    Crepaldi, G
    Schnitzer, T
    Smith, I
    Marcus, R
    Gopalakrishnan, G
    Greenwald, M
    Kiel, D
    Lipschitz, S
    Foldes, J
    Orloff, J
    Santora, A
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S6 - S6
  • [25] Upper gastrointestinal and overall tolerability of alendronate once weekly in patients with osteoporosis: results of a randomized, double-blind, placebo-controlled study
    Eisman, JA
    Rizzoli, R
    Roman-Ivorra, J
    Lipschitz, S
    Verbruggen, N
    Gaines, KA
    Melton, ME
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (05) : 699 - 705
  • [26] Two-year gastrointestinal safety and tolerability of alendronate 70mg once weekly.
    Genco, RJ
    Van Dyke, T
    Leung, A
    Meng, L
    Ritter, S
    Grossman, S
    Salzmann, G
    Lombardi, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S528 - S528
  • [27] Upper GI tolerability of once-weekly alendronate 70 mg with concomitant NSAID use.
    de Papp, AE
    Palmisano, J
    Geba, GP
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S473 - S473
  • [28] Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: A randomized double-blind study
    Rosen, CJ
    Hochberg, MC
    Bonnick, SL
    McClung, M
    Miller, P
    Broy, S
    Kagan, R
    Chen, E
    Petruschke, RA
    Thompson, DE
    de Papp, AE
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (01) : 141 - 151
  • [29] TREATMENT WITH ONCE-WEEKLY ALENDRONATE 70 MG COMPARED TO ONCE-WEEKLY RISEDRONATE 35 MG IN WOMEN WITH POSTMENOPAUSALE OSTEOPOROSIS: A RANDOMIZED DOUBLE-BLIND STUDY
    Pietschmann, Peter
    JOURNAL FUR MINERALSTOFFWECHSEL, 2005, 12 (01): : 36 - 38
  • [30] The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis
    Yan, Yuxiang
    Wang, Wei
    Zhu, Hanmin
    Li, Mei
    Liu, Jianli
    Luo, Bangyao
    Xie, Haibao
    Zhang, Guangjian
    Li, Fuobao
    JOURNAL OF BONE AND MINERAL METABOLISM, 2009, 27 (04) : 471 - 478
12345